V029-9887 Screening compound: N-CYCLOHEXYL-N-{2-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]ETHYL}-1-CYCLOBUTANECARBOXAMIDE

V029-9887 Screening compound: N-CYCLOHEXYL-N-{2-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]ETHYL}-1-CYCLOBUTANECARBOXAMIDE
V029-9887 Screening compound: N-CYCLOHEXYL-N-{2-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]ETHYL}-1-CYCLOBUTANECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-9887
N-CYCLOHEXYL-N-{2-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]ETHYL}-1-CYCLOBUTANECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-9887

Molecular Formula

C22H29N3O3 (C22 H29 N3 O3)

Compound Name

N-CYCLOHEXYL-N-{2-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]ETHYL}-1-CYCLOBUTANECARBOXAMIDE

IUPAC name

N-cyclohexyl-N-{2-[3-(4-methoxyphenyl)-124-oxadiazol-5-yl]ethyl}cyclobutanecarboxamide

SMILES

COc(cc1)ccc1-c1noc(CCN(C2CCCCC2)C(C2CCC2)=O)n1

InChI

InChI=1S/C22H29N3O3/c1-27-19-12-10-16(11-13-19)21-23-20(28-24-21)14-15-25(18-8-3-2-4-9-18)22(26)17-6-5-7-17/h10-13,17-18H,2-9,14-15H2,1H3

InChI Key

LELUREVGKKDIEP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20493406

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

383.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.743

Distribution Coefficient, logD

4.743

Water Solubility, LogSw

-4.39

Polar Surface Area

54.811

Acid Dissociation Constant (pKa)

23.94

Base Dissociation Constant (pKb)

1.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

59.09

V029-9887 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V029-9887 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-9887?
Check Price and Availability of V029-9887, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-9887 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-9887
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-9887
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-9887 available by request